Ropes & Gray has advised Revolution Medicines. Revolution Medicines and BeOne Medicines have entered into a multi-part collaboration focused on clinical development and commercialization within the...
Revolution Medicines and BeOne Medicines Launch Multi-Part Oncology Collaboration
Shionogi Acquires Global Rights to RADICAVA Business from Tanabe Pharma Corporation for $2.5 Billion
Cleary Gottlieb Steen & Hamilton LLP has advised Shionogi & Co. Ltd. and Shionogi Inc.; Ropes & Gray LLP has advised Tanabe Pharma Corporation. Shionogi &...
Blackstone and TPG Announce $18.3 Billion Acquisition of Hologic
Kirkland & Ellis and Ropes & Gray have advised Blackstone and TPG. Wachtell, Lipton, Rosen & Katz has advised Hologic. Sidley has represented GIC. Blackstone and...
AstraZeneca’s $160 Million Acquisition of FibroGen China
Ropes & Gray represented FibroGen, Inc. in the transaction. FibroGen, Inc. (NASDAQ: FGEN) announced the sale of its China subsidiary, Fibrogen China, to AstraZeneca for approximately...
Rubicon Founders’ $165 Million Investment in Caidya
Ropes & Gray represented Rubicon Founders in the transaction, and Sidley Austin represented Caidya. Rubicon Founders announced its $165 million strategic growth investment in Caidya, a...
Zai Lab’s $200 Million Secondary Offering
Ropes & Gray represented Zai Lab Limited in the offering, while Simpson Thacher & Bartlett represented the underwriters. Zai Lab Limited (“Zai Lab” or the “Company”)...
Kailera Therapeutics’ $400 Million Series A Financing
Ropes & Gray advised Kailera Therapeutics, Inc. on the transaction. Kailera Therapeutics, Inc. (“Kailera”) announced raising $400 million in Series A financing. Kailera announced its launch...
Shanghai Voicecomm Information Technology’s US$85 Million Initial Public Offering
Ashurst acted as the U.S. counsel to Shanghai Voicecomm Information Technology, while O’Melveny represented the underwriters on the offering. Shanghai Voicecomm Information Technology Co., Ltd. (2495.HK)...
Laopu Gold’s HK$906 Million HKEX IPO
On the deal, O’Melveny acted for Laopu Gold, Linklaters advised the underwriters. Laopu Gold Co., Ltd. completed the global offering and listing of H shares on...
Becton, Dickinson and Company’s Acquisition of Critical Care Product Group of Edwards Lifesciences
Skadden is advising Edwards Lifesciences, while Ropes & Gray is providing legal counsel to BD on the deal. Edwards Lifesciences has entered into a definitive agreement...
Takeda Pharmaceuticals’ $1.2 Billion License Agreement with Degron Therapeutics
Ropes & Gray advised Takeda Pharmaceuticals on the deal. Takeda Pharmaceuticals announced it has entered into a collaboration and exclusive license agreement with Degron Therapeutics (“Degron”)...
Qyuns Therapeutics’ US$31 Million Initial Public Offering
O’Melveny represented China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and overall coordinator in the IPO. Qyuns Therapeutics Co., Ltd. (2509.HK) announced...